Fosbretabulin for the treatment of anaplastic thyroid cancer. (October 2014)
- Record Type:
- Journal Article
- Title:
- Fosbretabulin for the treatment of anaplastic thyroid cancer. (October 2014)
- Main Title:
- Fosbretabulin for the treatment of anaplastic thyroid cancer
- Authors:
- Granata, Roberta
Locati, Laura D
Licitra, Lisa - Abstract:
- ABSTRACT : Fosbretabulin tromethamine is a vascular disrupting agent, which is a type of drug that is designed to damage the vasculature (blood vessels) of cancer tumors, causing central necrosis. This drug showed activity against anaplastic thyroid cancer that was demonstrated in orthotopic xenograft models as well as in Phase I/II trials with or without carboplatin and paclitaxel combination therapy. In all of these studies, fosbretabulin was well tolerated.
- Is Part Of:
- Future oncology. Volume 10:Number 13(2014)
- Journal:
- Future oncology
- Issue:
- Volume 10:Number 13(2014)
- Issue Display:
- Volume 10, Issue 13 (2014)
- Year:
- 2014
- Volume:
- 10
- Issue:
- 13
- Issue Sort Value:
- 2014-0010-0013-0000
- Page Start:
- 2015
- Page End:
- 2021
- Publication Date:
- 2014-10
- Subjects:
- anaplastic thyroid cancer -- fosbretabulin -- tubulin-binding agent
Oncology -- Periodicals
616.99405 - Journal URLs:
- http://www.futuremedicine.com/loi/fon ↗
http://www.futuremedicine.com/ ↗ - DOI:
- 10.2217/fon.14.154 ↗
- Languages:
- English
- ISSNs:
- 1479-6694
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4060.610420
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 19485.xml